BioPorto Statistics
Total Valuation
BioPorto has a market cap or net worth of 104.54 million. The enterprise value is 97.16 million.
| Market Cap | 104.54M |
| Enterprise Value | 97.16M |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +13.18% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 454.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.78 |
| PB Ratio | 11.11 |
| P/TBV Ratio | 11.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.26 |
| EV / Sales | 17.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.34 |
Financial Position
The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.17.
| Current Ratio | 4.12 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.13 |
| Interest Coverage | -166.55 |
Financial Efficiency
Return on equity (ROE) is -106.68% and return on invested capital (ROIC) is -64.43%.
| Return on Equity (ROE) | -106.68% |
| Return on Assets (ROA) | -50.75% |
| Return on Invested Capital (ROIC) | -64.43% |
| Return on Capital Employed (ROCE) | -99.77% |
| Revenue Per Employee | 104,819 |
| Profits Per Employee | -197,368 |
| Employee Count | 48 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.91% in the last 52 weeks. The beta is 1.05, so BioPorto's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +30.91% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.74 |
| Average Volume (20 Days) | 46,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioPorto had revenue of 5.03 million and -9.47 million in losses. Loss per share was -0.02.
| Revenue | 5.03M |
| Gross Profit | 3.41M |
| Operating Income | -10.47M |
| Pretax Income | -10.24M |
| Net Income | -9.47M |
| EBITDA | -10.38M |
| EBIT | -10.47M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 8.28 million in cash and 1.55 million in debt, giving a net cash position of 6.73 million.
| Cash & Cash Equivalents | 8.28M |
| Total Debt | 1.55M |
| Net Cash | 6.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.41M |
| Book Value Per Share | 0.02 |
| Working Capital | 8.82M |
Cash Flow
In the last 12 months, operating cash flow was -11.60 million and capital expenditures -48,588, giving a free cash flow of -11.65 million.
| Operating Cash Flow | -11.60M |
| Capital Expenditures | -48,588 |
| Free Cash Flow | -11.65M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.68%, with operating and profit margins of -208.17% and -188.29%.
| Gross Margin | 67.68% |
| Operating Margin | -208.17% |
| Pretax Margin | -203.47% |
| Profit Margin | -188.29% |
| EBITDA Margin | -206.27% |
| EBIT Margin | -208.17% |
| FCF Margin | n/a |
Dividends & Yields
BioPorto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.18% |
| Shareholder Yield | -13.18% |
| Earnings Yield | -9.06% |
| FCF Yield | -11.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioPorto has an Altman Z-Score of 9.26.
| Altman Z-Score | 9.26 |
| Piotroski F-Score | n/a |